(2008). A comparison of linear array and line blot assay for detection of HPV and cervical precancer and cancer in the ASCUS LSIL triage study . J Clin Microbiol.
(2008). A comparison of two PCR-based human papillomavirus genotyping methods [published online ahead of print
A prospective study of age trends in cervical human papillomavirus acquisition and persistence
(2002). A prospective study of highgrade cervical neoplasia risk among human papillomavirus-infected women .
(2008). A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States . Cancer Epidemiol Biomarkers Prev .
(2006). American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. [published erratum appears
(2005). Cervical cancer in women with comprehensive health care access: attributable factors in the screening process .
(2008). Cervical cancer screening following prophylactic human papillomavirus vaccination [review] . Vaccine .
(1999). Cervical cancer screening: which techniques should be used and why? Clin Obstet Gynecol .
(2009). de la Rochefordière A , Savignoni A , et al . Different outcome of invasive cervical cancer associated with high-risk versus intermediate-risk HPV genotype .
(2001). Determinants of genital human papillomavirus detection in a US population . J Infect Dis .
(1999). Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identiﬁ cation of anogenital human papillomavirus . J Clin Microbiol.
(2003). Epidemiologic classiﬁ cation of human papillomavirus types associated with cervical cancer .
(2002). Genotyping of human papillomavirus by the PGMY-line blot and the SPF10-line probe assay in liquid cytology cervical specimens . J Clin Microbiol.
(2007). Health Protection Agency . Health Protection Report . 2007;1(35) . Health Protection Agency ;
(2001). Human papillomavirus and prognosis of invasive cervical cancer: a population-based study . J Clin Oncol .
(1992). Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types . Obstet Gynecol .
(1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide . J Pathol .
(1996). Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer .
(2007). Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a metaanalysis update .
(2000). Improved ampliﬁ cation of genital human papillomaviruses .
Incidence trends of adenocarcinoma of the cervix in
(2007). Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing [review] . Cancer .
(1958). Mortality from lung cancer and chronic obstructive pulmonary disease in
(1999). Natural history of dysplasia of the uterine cervix .
(1998). Novel short-fragment PCR assay for highly sensitive broad-spectrum detection of anogenital human papillomaviruses .
(2003). Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix . Cancer .
(2006). Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis . Lancet .
(1999). Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas . Cancer Epidemiol Biomarkers Prev .
(2007). Prevalence of HPV infection among females in the United States . JAMA .
(2008). Prevalence of type-speciﬁ c HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial .
(2005). Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse .
(2004). Projected clinical beneﬁ ts and costeffectiveness of a human papillomavirus 16/18 vaccine .
(2006). Relationships of human papillomavirus type, qualitative viral load, and age with cytologic abnormality . Cancer Res.
(1999). Risk factors for rapidonset cervical cancer .
(1994). Sample preparation and PCR ampliﬁ cation from parafﬁ n-embedded tissues . PCR Methods Appl.
(2003). Smoking and cervical cancer: pooled analysis of the IARC multi-centric case – control study . Cancer Causes Control .
(2006). Sustained efﬁ cacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial . Lancet .
(2005). The carcinogenicity of human papillomavirus types reﬂ ects viral evolution . Virology .
(2005). The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-speciﬁ c HPV testing in clinical practice . J Natl Cancer Inst .
(2007). The relationship of community biopsy-diagnosed cervical intraepithelial neoplasia grade 2 to the quality control pathology-reviewed diagnoses: an ALTS report . Am J Clin Pathol .
(2000). The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States — a 24-year population-based study . Gynecol Oncol .
(2008). Type-dependent integration frequency of human papillomavirus genomes in cervical lesions . Cancer Res.
(2000). Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix . Gynecol Oncol .
(2007). Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type .
(2004). zur Hausen HH . Classiﬁ cation of papillomaviruses . Virology .